Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Looking to make money this instant? Check out effective strategies that can help you earn cash right away.
13,356 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A private AI platform invites accredited investors join pre-ipo for early ownership at $0.85 per share, closing March...
SLV rose again this week as bearish chatter on social boards quieted and options hedging nudged the silver-focused ET...
Ford's fourth quarter shocked many investors: a massive net loss despite solid revenue. This article peels back the d...
A BAFTA ceremony moment involving Tourette syndrome sparked a global debate on stigma and language. This report exami...
FedEx says it will return tariff refunds to customers who paid them after a Supreme Court ruling curbed IEEPA tariffs...
A surge in AI and software stocks is driving big, daily swings in CEO wealth even as pay packages grow. Investors oft...
In several large markets, prices are softening while buyer interest remains steady. This article explains the forces ...
A Massachusetts case targets the forfeiture of $327K in Tether tied to an alleged dating-app crypto scam. Authorities...
Klarna has faced a sharp pullback this year, leaving investors wondering if the drop creates a buying opportunity. Th...
Deloitte issued an independent accountant’s report on Anchorage Digital Bank’s USAT Reserve Report, marking a milesto...
SpaceX is lining up a blockbuster IPO that could outpace the entire 2025 IPO slate. Analysts estimate a multi-billion...